A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

NCT02223884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma

Interventions

DRUG: docetaxel 35mg/m2
DRUG: Carboplatin AUC3

Sponsor

Yonsei University